2-methyl-thieno-benzodiazepine formulation
AssigneeEli Lilly and Company
InventorsDouglas J. Allen, Kurt D. Dekemper, Thomas H. Ferguson, Stuart J. Garvin, Linda C. Murray, Norman D. Brooks, Charles A. Bunnell, Snehlata S. Mascarenhas, Sharon L. Shinkle, Barry A. Hendriksen, David E. Tupper, Manuel V. Sanchez-Felix
Life of this patent
Estimating the term…
Abstract
The invention provides a pharmaceutically acceptable oleaginous or cholesterol microsphere formulation or olanzapine or olanzapine pamoate or solvates thereof. The invention further provides novel olanzapine pamoate salts or solvates thereof.
Claims26
A formulation comprising olanzapine pamoate salt or solvate thereof as an active ingredient and one or more carriers selected from the group consisting of an oleaginous carrier or cholesterol microsphere carrier.
A formulation comprising olanzapine pamoate salt or solvate thereof as an active ingredient, and one or more carriers.
A formulation comprising olanzapine pamoate salt or solvate thereof, and an oleaginous carrier.
A formulation comprising olanzapine pamoate salt or solvate thereof, and a cholesterol microsphere carrier.
Dependencies are inferred from the claim text.